⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14364243 | 0.75 | — | — | |
| SCHEMBL24961187 | 0.71 | — | — | |
| SCHEMBL21446112 | 0.69 | — | — | |
| SCHEMBL24059291 | 0.69 | — | — | |
| SCHEMBL19311478 | 0.67 | — | — | |
| SCHEMBL11955021 | 0.67 | — | — | |
| SCHEMBL22628814 | 0.67 | — | — | |
| SCHEMBL19828477 | 0.65 | TAS2R38 (0.30) | — | |
| SCHEMBL23230280 | 0.65 | — | — | |
| SCHEMBL19772390 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230320112-A1 | POLYMERS, FORMULATIONS, ORGANIC OPTOELECTRONIC DEVICES, AND APPLICATIONS THEREOF | Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) | 2023-10-05 | — | — | US | disclosed |
| WO-2021081881-A1 | FUNCTIONAL CARBOHYDRATE MOLECULE BASED ON TDG MOLECULAR SCAFFOLD, AND PREPARATION METHOD THEREFOR | 深圳先进技术研究院 | 2021-05-06 | — | — | WO | disclosed |
| WO-2021032209-A1 | ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF | 四川海思科制药有限公司 | 2021-02-25 | — | — | WO | disclosed |
| EP-3575298-A1 | FUSED HETEROCYCLIC COMPOUND AND COMPOSITION CONTAINING SAME | Sumitomo Chemical Company Limited (JP) | 2019-12-04 | — | — | EP | disclosed |
| US-20170240589-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. | 2017-08-24 | — | — | US | disclosed |
| EP-2311851-A2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-04-20 | — | — | EP | disclosed |
| EP-2230254-A2 | Anti-IGFR1 antibody therapeutic combinations | Schering Corporation (US) | 2010-09-22 | — | — | EP | disclosed |
| EP-1689782-B1 | ANTI-IGFR1 ANTIBODY THERAPEUTIC COMBINATIONS | SCHERING CORP (US) | 2010-04-21 | — | — | EP | disclosed |
| WO-2009143156-A2 | IMIDAZO[1,2-a]PYRIDINE COMPOUNDS | SEPRACOR INC. (US) | 2009-11-26 | — | — | WO | disclosed |
| WO-2008141011-A1 | 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS | AMIRA PHARMACEUTICALS, INC. (US) | 2008-11-20 | — | — | WO | disclosed |